Proactive Investors - Run By Investors For Investors

MedMen’s fiscal 1Q sales rocket 1,094% as losses widen due to expansion

Strong results in California drove MedMen’s fiscal first-quarter revenue to $21.5 million from the $1.8 million in the first quarter of fiscal 2018
A MedMen package
MedMen now operates over 14 retail stores in California, Nevada and New York as well as cultivation and production facilities

MedMen Enterprises Inc (CSE:MMEN) (OTC:MMNFF) reported a spectacular 1,094% jump in sales late Thursday for the first quarter of fiscal 2019 on widening losses due to rapid expansion.   

For the quarter ended September 2018, the California-based cannabis grower and retailer reported losses of US$66.5 million, or US$1.42 per share. This was an improvement on net losses of US$78.7 million, or US$1.95 per share for the fourth quarter last year.

The picture wasn’t entirely gloomy, however. The opening of additional retail stores and strong results in California drove MedMen’s revenue to US$21.5 million a 1,094% jump over the US$1.8 million in the first quarter of fiscal 2018.

The company continued territorial expansion in six key markets by closing the acquisition of Treadwell Nursery in Florida and opening its first branded retail store in downtown Las Vegas.

“Our first quarter performance underlines the successful execution of our growth strategy and ongoing commitment to provide mainstream cannabis consumers a wide breadth of products for their lifestyle and wellness needs,” said MedMen co-founder and CEO Adam Bierman.

Bierman said MedMen was now entering “a new phase” focused on “fully operationalizing” its large footprint.

“Our four-pillars strategy built around a quality team, superior assets, strong balance sheet and the ability to efficiently and effectively raise and deploy capital has set us up to successfully achieve our vision,” said Bierman.  

READ: MedMen’s latest acquisition to expand its presence in the Arizona cannabis market

MedMen has been acquiring cannabis companies left and right and recently signed a letter of intent to acquire medical cannabis company PharmaCann in a US$682 million deal.

The California-based company has also acquired control of Kannaboost Technology Inc and CSI Solutions LLC in a cash and stock deal valued at US$33 million.

The companies comprise Level Up, which holds licenses for two vertically integrated operations in Arizona, including retail locations in Scottsdale and Tempe. Level Up also operates 25,000 square feet of cultivation and production capacity in Tempe and Phoenix.

MedMen now operates a total of 14 retail stores in California, Nevada and New York as well as cultivation and production facilities.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MMEN profile View Profile

MedMen Enterprises Inc Timeline

Newswire
December 06 2018
Article
October 24 2018

Related Articles

cannabis extract
January 16 2019
The Kelowna, BC-based cannabis company specializes in the research, development, production, and testing of high-quality cannabis extracts and oils
Sydney Harbour Bridge
January 22 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use